Study: CLL Therapies Cannot Overcome Increased Infection, Malignancy Risk AJMC, 23 Jan 2024 A new comparison of chemoimmunotherapy and ibrutinib (Imbruvica; Pharmacyclics/Janssen Biotech) in patients with chronic…